Seroba Life Sciences is a European life sciences venture capital firm based in Dublin, focused on backing innovative biotech and medtech companies. Founded in 2002, the firm invests from its Fund IV, which closed at €123M ($134M).
41% of their portfolio is in Healthcare. Their most common stage is series-b (41% of deals). Average disclosed round size is $42.4M (across 16 rounds with reported amounts).
Portfolio
25
Fund Size
$134M
Top Stage
Series B
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
37 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Deciphex | Series C | — | Jan 2025 |
 Coave Therapeutics | Series A | $32M | Jan 2025 |
| LLoci Orthopaedics | Series A | — | Jul 2024 |
 Complement Therapeutics | Series A | — | Apr 2023 |
| CComplement | Series A | — | Apr 2023 |
| Deciphex | Series B | — | Jan 2023 |
 Shorla Oncology | Series B | $35M | Jan 2023 |
 Storm Therapeutics | Series B | $30M | Dec 2022 |
 SibYlla | Series A | — | Oct 2022 |
 Sibylla Biotech | Series A | — | Oct 2022 |
| Deciphex | Series B | $11.5M | May 2022 |
| Sibylla Biotech | Series A | — | Jan 2022 |
| Deciphex | Series B | — | Jan 2022 |
| Coave Therapeutics | Series B | — | Jul 2021 |
 Coave Therapeutics | Series B | $21.2M | Jul 2021 |
 Palliare | Series A | $8M | Jul 2021 |
 Atlantic Therapeutics | Bridge | — | Jan 2021 |
| SSHORLA PHARMA LIMITED | Series A | $8.3M | Jun 2020 |
| Shorla Oncology | Series A | $8M | Jan 2020 |
 Quanta Dialysis Technologies | Series C | $38M | Jul 2019 |
| PPQ Bypass | Series C | $60M | Jan 2019 |
| Atlantic Therapeutics | Series B | — | Jan 2019 |
 FoodMarble | Series A | — | Jan 2019 |
 Endotronix | Series D | $45M | Sep 2018 |
| FFusion Pharmaceuticals | Series A | $46M | Sep 2017 |
Page 1 of 2
Top Co-Investors
Enterprise Ireland10 shared
Forbion7 shared
Ysios Capital5 shared
M Ventures4 shared
Sunstone Life Science Ventures4 shared
Earlybird Venture Capital4 shared
Kurma Partners4 shared
EQT Life Sciences3 shared
Cambridge Innovation Capital3 shared
Claret Capital Partners3 shared
3B Future Health Fund3 shared
Vi Partners3 shared
Vertis SGR3 shared
CDP Venture Capital3 shared
Indaco3 shared
Andera Partners3 shared
Atlantic Bridge3 shared
Irrus Investments3 shared
Idinvest3 shared
Fund+3 shared
Last updated: 20 October 2026